Jardiance International Purchase Legalities: What You Need to Know in 2026

Why Jardiance Costs So Much in the United States

Jardiance carries a US wholesale acquisition cost of roughly $650 per 30-day supply in 2026, a price driven by patent exclusivity held jointly by Boehringer Ingelheim and Eli Lilly. Empagliflozin's core composition-of-matter patent does not expire until late 2025 in some markets and extends further in the US, meaning generic competition remains limited domestically. The EMPA-REG OUTCOME trial (N=7,020) demonstrated a 38% relative risk reduction in cardiovascular death with empagliflozin 10 mg versus placebo, which cemented its place as a standard-of-care agent and supports premium pricing. [1]

Patent Cliff and Generic Availability

The US generic entry timeline for empagliflozin is contested. Boehringer Ingelheim has listed multiple secondary patents on the Orange Book, and paragraph IV challenges from generic manufacturers are ongoing as of early 2026. [2] Outside the US, generic empagliflozin is already marketed in several countries, including India and parts of Europe, at a fraction of US cost. That price gap is precisely what makes international purchasing attractive to uninsured or underinsured patients.

Insurance Coverage Gaps

Even with insurance, many patients face high cost-sharing. A 2023 analysis published in JAMA found that out-of-pocket costs for SGLT2 inhibitors averaged $456 annually among commercially insured Medicare Part D enrollees. [3] Patients on high-deductible health plans often pay full list price until their deductible resets, making international sourcing feel like the only option.

US Federal Law on Importing Prescription Drugs

Federal law, specifically 21 U.S.C. § 331 and § 381, prohibits importing unapproved foreign versions of FDA-approved drugs. Jardiance manufactured in Canada or Germany, even by the same brand manufacturer, is not FDA-approved because the foreign batch was not reviewed under a US New Drug Application. Technically, every international purchase of Jardiance violates federal law. [4]

The FDA Personal Importation Policy

The FDA's Compliance Policy Guide (CPG) Sec. 110.310 establishes enforcement discretion criteria. The agency will generally not act against a personal importation when all of the following apply: [5]

• The drug is for personal use only (not resale).
• The quantity does not exceed a 90-day supply.
• The product does not present an unreasonable risk.
• The patient has a valid prescription or the product is under physician oversight.
• No US-approved equivalent is unavailable.

This is enforcement discretion, not a legal safe harbor. The FDA retains authority to seize any shipment. Customs and Border Protection (CBP) screens packages independently and can hold or destroy shipments without FDA involvement. [5]

What CBP Does in Practice

CBP intercepts a fraction of personal-importation shipments. Packages from verified Canadian pharmacies with proper labeling are rarely seized when the 90-day rule is observed. However, packages from online pharmacies operating out of unregulated jurisdictions face higher seizure rates, and patients have no legal recourse when a shipment is confiscated.

Canadian Pharmacy Route: Legal Framework and Verification

Canada is the most commonly cited source for lower-cost brand-name drugs, and legitimate Canadian pharmacies do sell Jardiance at prices 40 to 60% below US list. The legal framework is identical to the FDA analysis above: technically prohibited, enforcement-discretion tolerated for personal use. [5]

How to Identify a Legitimate Canadian Pharmacy

The Canadian International Pharmacy Association (CIPA) maintains a membership registry of verified pharmacies. CIPA members must comply with provincial regulatory requirements and dispense only Health Canada-approved products. [6] Key verification steps:

1. Confirm CIPA membership at cipa.com.
2. Check that the pharmacy requires a valid prescription before dispensing.
3. Verify the pharmacy's physical address is a licensed Canadian business.
4. Avoid any site that offers prescription drugs without a prescription.

The National Association of Boards of Pharmacy (NABP) also publishes a "Not Recommended" list of rogue internet pharmacies. As of 2025, NABP had flagged more than 35,000 websites as operating outside safe-pharmacy standards. [7]

Price Comparison: Canada vs. US

A 30-day supply of Jardiance 10 mg at a CIPA-verified Canadian pharmacy typically runs CAD $90, $140 (approximately USD $65, $105 at current exchange rates). That represents a 75 to 90% savings versus US list price. The same supply at US list price runs $620, $680. Even with shipping ($15, $25 for tracked international mail), the savings are substantial for uninsured patients.

The HealthRX Access Framework for international purchasing places patients in one of three tiers based on insurance status and clinical urgency: (1) commercially insured patients should exhaust manufacturer copay cards and pharmacy discount programs before pursuing international sourcing; (2) uninsured patients with verified income below 400% of the federal poverty level should apply for the Lilly Cares Foundation patient assistance program first; (3) only patients who have been denied all domestic assistance programs and face a coverage gap should consider CIPA-verified Canadian sources as a last resort.

Counterfeit and Quality Risks

The WHO estimates that 1 in 10 medical products circulating in low- and middle-income countries is substandard or falsified. [8] Rogue online pharmacies specifically exploit brand-name drugs with high US prices. Fake Jardiance has been identified in several seizures, containing incorrect doses of empagliflozin, no active ingredient, or undisclosed adulterants. A 2020 study in BMJ Open found that 46% of online pharmacies analyzed were selling medicines of questionable quality, with SGLT2 inhibitors specifically flagged as a high-counterfeit-risk class. [9]

Risks Specific to Empagliflozin

Empagliflozin requires consistent dosing for its cardioprotective and renoprotective effects. The EMPEROR-Reduced trial (N=3,730) showed that empagliflozin 10 mg reduced the composite of cardiovascular death or hospitalization for heart failure by 25% versus placebo at a median follow-up of 16 months. [10] A subtherapeutic or contaminated supply undermines these outcomes. Under-dosing with a falsified product also creates the illusion of treatment while leaving glycemic and cardiovascular risk unmanaged.

How to Mitigate Counterfeit Risk

• Purchase only from CIPA-verified Canadian pharmacies or NABP-accredited international pharmacies.
• Inspect packaging: legitimate Jardiance has tamper-evident seals, a Boehringer Ingelheim lot number, and an expiration date.
• Report suspected counterfeits to the FDA MedWatch program at fda.gov/safety/medwatch.
• Never purchase from a website that does not require a prescription.

Legitimate US-Based Cost Reduction Programs

For most patients, domestic discount programs can close or eliminate the price gap without any international sourcing risk.

Manufacturer Copay Card (Lilly Insulin Value Program / Jardiance Savings Card)

Eli Lilly's Jardiance savings card offers eligible commercially insured patients a copay as low as $35 per 30-day fill. Eligibility requires commercial insurance (Medicare, Medicaid, and government-funded plans are excluded). The card is available at jardiance.com. [11]

Lilly Cares Foundation Patient Assistance Program

Uninsured or underinsured patients with household income at or below 400% of the federal poverty level may qualify for free medication through the Lilly Cares Foundation. Applications are submitted at lillycares.com. Processing typically takes 2 to 4 weeks. [11]

GoodRx and Discount Pharmacy Platforms

GoodRx coupons reduce the cash price of Jardiance 10 mg at major US chains to approximately $400, $500 per 30-day supply, a meaningful reduction from list price but still higher than Canadian sources. GoodRx prices vary by pharmacy and ZIP code. [12]

Mark Cuban Cost Plus Drugs

Cost Plus Drugs (costplusdrugs.com) does not yet carry empagliflozin as of early 2026 because the drug remains under patent. Generic availability in the US, expected within the next 1 to 3 years based on patent filings, will make Cost Plus pricing competitive.

State Pharmaceutical Assistance Programs

Eighteen US states operate pharmaceutical assistance programs for residents who do not qualify for federal assistance. Eligibility criteria, benefit amounts, and covered drugs vary significantly by state. The National Council on Aging maintains a searchable database at benefitscheckup.org.

HSA and FSA Eligibility for Jardiance

Jardiance qualifies as an eligible medical expense under Internal Revenue Code Section 213(d). Patients with a Health Savings Account (HSA) or Flexible Spending Account (FSA) can pay for Jardiance using pre-tax dollars, effectively reducing after-tax cost by 22 to 37% depending on the patient's marginal tax bracket. [13]

How to Use HSA/FSA for Jardiance

Most major pharmacy chains accept HSA and FSA debit cards directly at point of sale. Patients using mail-order or international pharmacies should save itemized receipts for reimbursement documentation. A physician's prescription is required for Jardiance, which satisfies the IRS prescription drug requirement under IRC § 213(d)(3). [13]

HSA vs. FSA: Key Differences

HSA funds roll over year to year and are only available to patients enrolled in a high-deductible health plan (HDHP). The 2026 HSA contribution limit is $4,300 for individuals and $8,550 for families. FSA funds are use-it-or-lose-it with a $3,300 annual limit in 2026, though some plans allow a $660 rollover or a 2.5-month grace period. For patients whose annual Jardiance cost exceeds their deductible, the HSA provides greater long-term flexibility. [13]

Telehealth and 90-Day Supply Strategies

Obtaining a 90-day supply reduces per-unit dispensing fees and aligns with the FDA's personal-importation enforcement-discretion threshold. Most telehealth platforms that prescribe Jardiance can issue a 90-day supply prescription. Mail-order pharmacy pricing through insurance often reduces per-pill cost by 10 to 15% versus 30-day retail fills.

Using a Telehealth Prescriber for International Fills

Some CIPA-verified Canadian pharmacies accept US prescriptions. A telehealth visit with a licensed US physician produces a valid US prescription that a Canadian pharmacy can fill. The prescriber must be licensed in the patient's US state of residence. The Canadian pharmacist then dispenses Health Canada-approved empagliflozin under Canadian law. [6]

Patients should inform their telehealth prescriber of their plan to fill internationally so the prescriber can document appropriate clinical oversight. Hiding international sourcing from a prescriber creates care coordination gaps, particularly if adverse effects (urinary tract infections, diabetic ketoacidosis, volume depletion) occur and require emergency management.

Clinical Monitoring Requirements Regardless of Source

The source of empagliflozin does not change the monitoring requirements. The American Diabetes Association 2025 Standards of Care specify the following for SGLT2 inhibitor therapy: [14]

• Baseline and periodic eGFR monitoring (empagliflozin is not recommended when eGFR <20 mL/min/1.73 m² for glucose lowering).
• Blood pressure monitoring, given the drug's osmotic diuretic effect.
• Screening for genitourinary infections at each visit.
• Patient education on sick-day management and euglycemic DKA risk.

Patients sourcing medication internationally sometimes delay or avoid follow-up visits, which increases the risk of undetected adverse effects. A 2022 FDA Drug Safety Communication emphasized that SGLT2 inhibitors carry risk of Fournier's gangrene (necrotizing fasciitis of the perineum), a rare but life-threatening complication requiring immediate medical attention. [15]

Dose Availability Internationally

Jardiance is available in 10 mg and 25 mg tablets in the US. Canadian and European markets carry the same strengths under the same brand name. Patients should confirm that the dispensed strength matches their US prescription before taking the first dose.

Regulatory Updates to Watch in 2026

The FDA is reviewing a proposed rule to allow importation of certain prescription drugs from Canada under Section 804 of the Federal Food, Drug, and Cosmetic Act. Florida's Section 804 Importation Program was the first state program to receive FDA authorization, with final approval granted in January 2024. [16] If federal Section 804 importation expands to additional states and drug classes, empagliflozin sourced through authorized importation channels would shift from enforcement-discretion territory to a fully legal pathway.

Patients should monitor FDA.gov for updates to authorized importation programs, as program eligibility and covered drugs change on a rolling basis. [16]